Zacks Research Brokers Decrease Earnings Estimates for BMY
Bristol Myers Squibb Company (NYSE:BMY - Free Report) - Investment analysts at Zacks Research cut their Q4 2025 earnings estimates for shares of Bristol Myers Squibb in a report issued on Thursday, November 13th. Zacks Research analyst Team now expects that the biopharmaceutical company will post ea

What's Your Reaction?











